Discover open access scientific publications

High Expression of BCL-2 and BCL-Xl in Diffuse Large B-Cell Lymphoma Confer Poor Prognosis but May Be Reversible by Combined Inhibition With Bet Inhibitors and Bh3 Mimetics.